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Cancer progression is an evolutionary process that is driven by mutation and selection in a population of tumor
cells. We discuss mathematical models of cancer progression, starting from traditional multistage theory. Each
stage is associated with the occurrence of genetic alterations and their fixation in the population. We describe the
accumulation of mutations using conjunctive Bayesian networks, an exponential family of waiting time models
in which the occurrence of mutations is constrained to a partial temporal order. Two opposing limit cases arise
if mutations either follow a linear order or occur independently. We derive exact analytical expressions for the
waiting time until a specific number of mutations have accumulated in these limit cases as well as for the general
conjunctive Bayesian network. Finally, we analyze a stochastic population genetics model that explicitly accounts
for mutation and selection. In this model, waves of clonal expansions sweep through the population at equidistant
intervals. We present an approximate analytical expression for the waiting time in this model and compare it to
the results obtained for the conjunctive Bayesian networks.
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I. INTRODUCTION
Cancer is a genetic disease that develops as the result of
mutations in specific genes. When these genes work normally,
they control the growth of cells in the body. Cancer cells have
lost the normal cooperative behavior of cells in multicellular
organisms resulting in increased proliferation. Tumor develop-
ment starts from a single genetically altered cell and proceeds
by successive clonal expansions of cells that have acquired ad-
ditional advantageous mutations. The progression of cancer
is characterized by the accumulation of these genetic changes
(Cairns, 1975; Crespi and Summers, 2005; Merlo et al., 2006;
Michor et al., 2004; Nowell, 1976).
Many oncogenes and tumor suppressor genes have been
identified that contribute to tumorigenesis (Futreal et al.,
2004). In general, the mutational patterns of cancer cells vary
greatly, not only among cancer types, but also among individ-
ual tumors of the same type. Some of this genetic variation
might be due to the fact that all cancer cells need to acquire
certain functional changes, the hallmarks of cancer, and most
of these functions are accomplished by several gene products
acting together in signaling pathways (Hanahan and Weinberg,
2000; Vogelstein and Kinzler, 2004). Thus, many different ge-
netic alterations can have similar phenotypic effects.
The incidence of sporadic cancer indicates that the underly-
ing events are stochastic and that, in general, several steps are
necessary. Therefore, a random processes approach appears to
be an appropriate modeling strategy. The progression stages
are generally not observable on a molecular level in vivo, and
in a clinical setting, patients are typically diagnosed at the fi-
nal stages of tumorigenesis. Mathematical modeling plays an
important role in cancer research today, because it can be used
to reconstruct and to analyze the evolutionary process driving
cancer progression (Anderson and Quaranta, 2008).
Models of tumorigenesis have been proposed early on to ex-
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plain cancer incidence data (Armitage and Doll, 1954; Knud-
son, 1971; Nordling, 1953). These models assume that cancer
is a stochastic multistep process with small transition rates and
they have been further developed into the multistage theory
of cancer (Frank, 2007; Jones et al., 2008a; Moolgavkar and
Luebeck, 1992). The tumor stages may be defined by specific
mutations, by the number of mutations, by epigenetic changes,
by functional alterations, or by histological properties. Since
cancer progression is an evolutionary process, population ge-
netics models are used extensively to describe tumorigene-
sis (Beerenwinkel et al., 2007a; Durrett et al., 2008; Nowak,
2006; Schinazi, 2006; Wodarz and Komarova, 2005). Various
deterministic and stochastic models have been proposed, some
of which address specific questions, such as the dynamics of
tumor suppressor genes (Iwasa et al., 2005), genetic instabil-
ity (Nowak et al., 2006), or tissue architecture (Nowak et al.,
2003).
As more and more genetic data from cancer cells become
available from comprehensive studies (Jones et al., 2008b; Ley
et al., 2008; Parsons et al., 2008; Sjo¨blom et al., 2006; Wood
et al., 2007) and through databases (Baudis, 2007; Futreal
et al., 2004; Mitelman et al., 2008), one can also start inves-
tigating the dependencies between genetic events using sta-
tistical models. In view of multistage theory, tumors pro-
ceed through distinct stages, which can be characterized by
the appearance of certain mutations. Particular attention has
been paid to inferring the order of genetic alterations. Several
graphical models have been developed for this purpose and
applied to various cancer types (Beerenwinkel and Sullivant,
2008; Beerenwinkel et al., 2006, 2007b; Desper et al., 1999;
Hjelm et al., 2006; Radmacher et al., 2001; Rahnenfu¨hrer
et al., 2005).
A quantitative understanding of carcinogenesis can help de-
veloping new diagnostic and prognostic markers. Today a va-
riety of univariate genetic markers is known (Sidransky, 2002),
most of them comprising well-known oncogenes or tumor sup-
pressors. Because of the diverse genetic nature of cancer,
markers measuring the accumulation of several mutations, i.e.,
the progression of cancer, may improve existing ones. Here,
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FIG. 1 The multistage model. Cancer is assumed to develop in a
linear process consisting of k stages. The progression steps mark the
major transitions of the tissue from normal to cancerous and even-
tually to metastasizing. At each transitions ( j − 1)→ j the waiting
time follows an exponential distribution with parameter u j giving rise
to the model defined by Eq. (1).
we investigate the dynamics of cancer progression as a func-
tion of transition rates and of order constraints on the genetic
events. The expected waiting time can be regarded as a mea-
sure of genetic progression to cancer (Rahnenfu¨hrer et al.,
2005).
In Section II, we introduce the general stochastic multistep
process and present an equivalent description in terms of or-
dinary differential equations (ODEs). At this abstract level
of description, carcinogenesis may be regarded as proceed-
ing through distinct stages, which can be defined by histolog-
ical grades, functional changes, or genetic alterations. In Sec-
tion III, these stages will be associated with the occurrence of
a certain number of mutations. We present expressions of the
waiting time until a given stage is reached, for different models
of mutation. Finally, in Section IV, we analyze an evolutionary
model of carcinogenesis explicitly describing the appearance
of genetic alterations in the tissue by mutations in single cells
and their subsequent clonal expansions.
II. MULTISTAGE THEORY
The multistage theory of cancer postulates that tumorigene-
sis is a linear multistep process, in which each step from one
stage to the next is a rare event (Figure 1). Let us denote the
cancer stages by 0, 1, 2, . . . , k, where stage 0 refers to the nor-
mal precancerous state, 1 to the first adenomatous stage, and k
to a defined cancerous endpoint, such as the the formation of
metastases. The process is started at time t = 0 in state 0.
The transition rate from stage j−1 to stage j is denoted u j .
That is, the waiting times for the transitions to occur are as-
sumed to be independently exponentially distributed. Here, the
coefficients u j denote the transition rates between the stages of
tumor development; later we will link them to different models
of mutation and fixation. Because of the sequential nature of
the linear model, the waiting time τk until stage k is reached is
given recursively by the sum of exponentially distributed ran-
dom variables,
τ1 ∼ Exp(u1), τ j ∼ τ j−1 + Exp(u j ), j = 2, . . . , k.
(1)
The waiting times follow the linear order τ1 < · · · < τk and
the expected waiting time is
E[τk] = E[τk−1]+ 1uk =
k∑
j=1
1
u j
. (2)
In particular, if all transition rates are equal, u j = u for all
j = 1, . . . , k, we find E[τk] = k/u. Hence the waiting time
scales linear in the number of transitions k.
Let fτ1,...,τk (t1, . . . , tk) be the density function of the joint
distribution of waiting times τ = (τ1, . . . , τk) defined by
Eq. (1). The linear order of the waiting times τ j induces the
factorization
fτ1,...,τk (t1, . . . , tk) =
k∏
j=1
fτ j |τ j−1(t j | t j−1) (3)
of fτ1,...,τk into the conditional densities
fτ j |τ j−1(t j | t j−1) = u j exp
(−u j [t j − t j−1]) I(t j > t j−1),
(4)
where I is the indicator function.
Multistage theory can also be formulated as a system of or-
dinary differential equations (ODEs). We derive this formula-
tion as follows: Let x j (t) denote the probability that stage j is
reached before time t ≥ 0, but stage j + 1 has not yet been
reached,
x0(t) = Prob[0 < t < τ1]
x j (t) = Prob[τ j < t < τ j+1], j = 1, . . . k − 1, (5)
xk(t) = Prob[τk < t].
We have x0(t) + · · · + xk(t) = 1 and x j (t) = Prob[t <
τ j+1]− Prob[t < τ j ] due to the linearity of transitions. It fol-
lows that x˙ j (t) = fτ j+1(t) − fτ j (t).Using the conditional ex-
ponential nature of the model, Eq. (4), one finds that fτ j (t) =∫∞
0 fτ j ,τ j−1(t, t
′) dt ′ = ∫ t0 exp(−u j [t − t ′]) fτ j−1(t ′) dt ′. From
the identity exp(−u j t) = u j
∫∞
t exp(−u j t ′) dt ′, one obtains
fτ j (t) = u j
∫ ∞
t
∫ t
0
exp(−u j [t ′′ − t ′]) fτ j−1(t ′) dt ′ dt ′′
= u j
∫ ∞
t
∫ t
0
fτ j ,τ j−1(t
′′, t ′) dt ′ dt ′′ (6)
= u j Prob[τ j−1 < t < τ j ] = u j x j−1(t).
Hence, the probabilities x j (t) obey the set of ODEs,
x˙0(t) = −u1 x0(t),
x˙ j (t) = u j x j−1(t)− u j+1x j (t), j = 1, . . . , k − 1, (7)
x˙k(t) = uk xk−1(t),
subject to initial conditions x0(0) = 1 and x j (0) = 0 for all
j ≥ 1. These rate equations describe the linear chain of ex-
ponential waiting time processes as a probability flux of rate
u j x j−1(t) from state j − 1 to state j .
If all rates are identical, u j = u for all j , then the solution
of this linear system of ODEs is given by Poisson distributions
with time-dependent parameter ut ,
x j (t) = Pois( j; ut) = (ut)
j exp(−ut)
j!
, j = 0, . . . , k − 1.
(8)
3The probability of having reached the final stage of progres-
sion, k, at time t is
xk(t) = 1− e−ut
k−1∑
j=0
(ut) j
j!
= Pois(k; ut)
∞∑
j=0
(ut) j
(k + j) j . (9)
We also recover from the ODE system the expected waiting
time to the final cancer stage,
E[τk] =
∫ ∞
0
utxk−1(t) dt = ku . (10)
Multistage theory provides a mathematical framework for
describing the stepwise progression of cancer. For the above
discussion of the model, we have neither specified the defini-
tion of the postulated stages, nor the nature of the transitions.
Indeed, different interpretations and uses of the model are pos-
sible. In the following we link multistage theory closely to the
genetic progression of cancer.
III. GENETIC PROGRESSION OF CANCER
In this section, we associate the stages of tumorigenesis to
mutations in the genomes of cancer cells. Each stage is defined
by the number of mutations that have accumulated in the cells
of the tissue. Each mutation occurs initially in a single cell as
the result of an erroneous DNA duplication. Some mutations
alter the behavior of the cell in such a way that it experiences a
growth advantage relative to the other cells in the tissue. These
cells can outgrow their competitors in a clonal expansion and
the mutation spreads in the tissue. While the first appearance
of a mutation is essentially a random process, i.e., each mu-
tation is equally likely to appear, the fate of a mutation in the
population depends on the relative fitness of the cell in which
it occurs.
We define tumor progression to be in stage j of the multistep
model, Eq. (1), if most of the tumor cells harbor exactly j mu-
tations. We are interested in the waiting time until k out of d
possible mutations have accumulated, where typically k  d.
For example, (Sjo¨blom et al., 2006) suggest that k ≈ 20 genes
out of d ≈ 100 to 1000 need to be hit in order to develop
invasive colon cancer. In this interpretation of multistage the-
ory, stages correspond to population states and transitions cor-
respond to genetic transformations of the ensemble of tumor
cells, including mutation and selection. These population dy-
namics will be investigated in more detail in the next section.
The focus of the present section is on how different models of
accumulating mutations affect the waiting time.
Genetic mutations occur randomly at erroneous cell divi-
sions, but the subsequent fixation of the mutation within the
cell population is constrained: A mutation will only spread if
it confers a growth advantage. This restricts not only the mu-
tations driving cancer, but also the order in which they can
appear, because some physiological changes must be achieved
before others. For example, in colon cancer, cells must lose the
ability to undergo apoptosis, before additional mutations accu-
mulate in the resulting neoplasia. Hence loss of function of the
tumor suppressor gene APC controlling apoptosis is necessary
before other mutations such as KRAS2 can fixate (Nowak et al.,
2003; Vogelstein and Kinzler, 2004). Furthermore, sometimes
only the combined action of mutations drives cancer progres-
sion. It is known, for example, that only the combination of
p53 and Ras trigger the development of tumors in mice (Land
et al., 1983).
In general, there may exist several order constraints for the
successive fixation of mutations as shown in Figure 2. The
simplest of these constraints is the linear model, where the
waiting times of all mutations are totally ordered (Figure 2(a)).
The linear model is exactly the multistep process discussed in
the previous section. Alternatively, mutations may occur inde-
pendently without any constraints (Figure 2(b)). If there exist
order relations among some of the possible mutations, a partial
order may be used to describe the process of accumulating mu-
tations (Figure 2(c)). We will discuss these models separately
and show how the topology of the genotype space affects the
waiting time.
Let d be the number of possible mutations and denote by T j
the waiting time for mutation j ( j = 1, . . . , d) to be generated
and to establish in the tumor. The waiting times T j are as-
sumed to be exponentially distributed with parameters λ j , and
they obey certain temporal order constraints (Figure 2). The
joint distribution of T = (T1, . . . , Td) determines how long
it takes until k out of the d mutations have accumulated. We
define the random variable τk denoting stage k as the waiting
time until any k mutations appear,
τk = min{ j1,..., jk }⊂[d] max {T j1 , . . . T jk }, [d] = {1, 2, . . . , d}.
(11)
If all mutations accumulate in a linear order (Figure 2(a)), each
at rate λ j ,
T1 ∼ Exp(λ1), T j ∼ T j−1 + Exp(λ j ), j = 2, . . . , d,
(12)
then τk = Tk and the process of mutation and clonal expansion
is mathematically equivalent to the general linear multistep
process of Eq. (1). In this case, the transition rates u j = λ j
may be interpreted as an effective rate for the mutation and
the clonal expansion process. According to Eq. (2) the waiting
time for k < d mutations is given by E[τk] =∑kj=1 1/λ j and
the waiting time scales linear with the number of mutations.
3.1. Independent mutations
Let us now consider the situation where all mutations may
occur in an arbitrary order (Figure 2(b)),
T j ∼ Exp(λ j ), j = 1, . . . , d. (13)
If k = 1, Eq. (11) simplifies to
τ1 = min{T1, . . . , Td} ∼ Exp(λ1 + · · · + λd) (14)
and the expected waiting time is E[τ1] = 1/∑dj=1 λ j . If all
fixation rates are equal to λ, then E[τ1] = 1/(dλ). Thus, the
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FIG. 2 Conjunctive Bayesian networks. Displayed are the Hasse dia-
grams of the posets representing the graph of the underlying Bayesian
network (left) and their corresponding genotype lattices (right) for
d = 3 mutational events. In the Hasse diagrams, each directed edge
i → j denotes a direct dependency between two mutational events
i ≺ j ; each node j is associated with an exponential waiting time
process with parameter λ j conditioned on the prevalence of all mu-
tations with directed edges to j . The genotype lattice is the lattice of
order ideals of the poset. It consists of all genotypes that are com-
patible with the relations of the poset. A directed edge S → T is
drawn between two genotypes S, T ⊂ [d], if T arises from S by a
mutation j ∈ T and if the transition from S to T is consistent with
the poset, i.e. there exists no i ≺ j with i 6∈ S. Mutations accu-
mulate along the different paths from ∅ to [d] in the genotype lat-
tice. Three network topologies are shown: a linear chain of mutations
(a), independent mutations (b), and a poset in which both mutation
1 and mutation 2 need to occur before mutation 3 (c). These posets
induce different genotype lattices, namely a single path (a), the com-
plete d-dimensional hypercube (b), and a lattice of intermediate size
(c), respectively.
occurrence of any one out of d mutations is equivalent to a
1-step process at rate u1 = dλ.
For now, we continue assuming identical rates λ. If k ≥ 2
and the first mutation has occurred, then there are d−1 choices
left for the second mutation to occur, hence τ2 ∼ τ1+Exp((d−
1)λ). In general, the accumulation of k out of d mutations,
which occur independently at the same rate λ, is equivalent to
the k-step process, Eq. (1), with rates u j = (d− j+1)λ. From
Eq. (2), we find
E[τk] = 1
λ
k∑
j=1
1
d − j + 1 . (15)
If many mutations are possible, d  k, then the expected wait-
ing time for k mutations is approximately E[τk] ≈ k/(dλ),
which is smaller than 1/λ and linear in k. The waiting time
approaches zero in the limit d → ∞ for every fixed k, be-
cause the exponential distribution is non-zero at t = 0. On
the other hand, if k = d, all possible mutations need to occur
and E[τk] = Hk/λ, where Hk = ∑kj=1 1/j is the k-th har-
monic number. Using Hk ≈ γ + log k, γ ≈ 0.577 being the
Euler-Mascheroni constant, we find an approximate logarith-
mic dependency for the occurrence of all possible mutations,
E[τk] ≈ (γ + log k)/λ. In contrast to the k  d case, for
k = d , the expectation of τk is larger than 1/λ and increases
only logarithmically in k.
In both cases the expected waiting time is always larger if
mutations can only occur in a linear fashion, Eq. (2), than if
mutations are independent, Eq. (15). This is due to the fact that
in the independent case, all mutations are possible in any step
of the process, whereas in the linear case, only one mutation is
feasible at each stage.
The ODE system, Eq. (7), corresponding to the multistage
model with unequal transition rates u j = (d− j+1)λ has also
an analytical solution. For j = 1, . . . , d,
x j (t) =
(
d
j
) (
1− e−ut) j (e−ut)d− j . (16)
If k  d, then u j ≈ dλ and Eq. (8) yields x j (t) ≈
Pois( j; dλt). Thus, the number of independent mutations ac-
cumulates at a speed that is roughly d times faster than for a
linear chain of mutations.
We now turn to the case of independent mutations with ar-
bitrary fixation rates λ j . The distribution of τ1 is given by
Eq. (14) with expected value 1/
∑d
j=1 λ j . If k ≥ 2, then for
the second mutation there are d − 1 choices. However, the
rate at which the second mutation occurs now depends on the
specific realization of the first mutation. Hence, we have to
consider the set Ck of all total orderings
T j1 < · · · < T jk (17)
of k out of d waiting times. There are (d)k = d!/(d− k!) such
orders. We identify Ck with the set of all mutational pathways
j1 → · · · → jk of length k in 2[d]. For notational convenience,
we write such a path C ∈ Ck as a collection of subsets C =
(C0,C1, . . . ,Ck) such that C0 = ∅ and Ci = ∪i`=1{ j`}, for
i = 2, . . . , k. Each set Ci represents an intermediate genotype
on the path with i mutations.
The expected waiting time until any k out of d mutations oc-
cur is the weighted sum over all mutational pathways of length
k,
E[τk] =
∑
C∈Ck
E[τk | C] Prob[C], (18)
5where
Prob[C] =
k∏
i=1
λ ji∑
j∈Exit(Ci−1) λ j
, (19)
is the probability of pathway C with { ji } = Ci \ Ci−1 and
Exit(Ci−1) = [d]\Ci−1 being the set of all possible mutations
at step i . Furthermore,
E[τk | C] =
k∑
i=1
1∑
j∈Exit(Ci−1) λ j
(20)
is the expectation of the waiting time τk given that the path
C is realized. For a fixed pathway, say 1 → · · · → k, the
waiting time distribution is Exp(λ1 + · · · + λd) for the first
mutation,, Exp(λ2 + · · · + λd) for the second mutation, and
Exp(λ j + · · · + λd) for the j-th mutation. In general, Eq. (20)
arises from a linear k-step process, Eq. (1), with transition rates
u j = ∑`∈Exit(C j−1) λ`. Note that this waiting time is differ-
ent from the waiting time in the linear model, because here
a linear pathway is considered within a much larger lattice
of mutational patterns (Figure 2(b)). In the denominators of
both Eqs. (19) and (20) we account for alternative evolution-
ary routes by summing over the fixation rates of all mutations
that could have occurred at this point.
If all fixation rates are identical to λ, then Prob[C] = 1/(d)k
and E[τk | C] = ∑ki=1 1/(d − i + 1)λ are independent of C ,
and we recover Eq. (15).
3.2. Partially ordered mutations
Sequentially and independently accumulating mutations can
be regarded as two opposite extreme cases, where the linear
model imposes maximum constraints on the order in which
mutations can occur, while the independent model imposes
none. For most biological systems, including cancer progres-
sion, we expect more realistic models to lie somewhere in be-
tween these extremes (Figure 2(c)). Conjunctive Bayesian net-
works are a class of waiting time models that allow for partial
orders among the mutations, i.e., they encode constraints like
Ti < T j for some of the mutations (Beerenwinkel and Sulli-
vant, 2008; Beerenwinkel et al., 2006, 2007b).
Formally, the (continuous time) conjunctive Bayesian net-
work is defined recursively by a partially ordered set, or poset,
P = ([d],≺) and fixation rates λ j , as
T j =
{
max
i∈pa( j)
Ti
}+ Exp(λ j ), j = 1, . . . , d, (21)
where pa( j) = {i | i ≺ j and (i ≺ ` ≺ j ⇒ i = ` or ` =
j)} is the set of mutations that cover mutation j . This model
class includes the linear and the independent model, for which
|pa( j)| = 1 and pa( j) = ∅, respectively. It is a Bayesian
network model, because the joint density of T = (T1, . . . , Td)
factors into conditional densities as
fT1,...,Td (t1, . . . , td) =
d∏
i=1
fTi |{T j : j∈pa(i)}(ti | {t j : j ∈ pa(i)})
=
d∏
i=1
λi exp
(−λi [ti − max
j∈pa(i)
t j ]
)
I
(
ti > max
j∈pa(i)
t j
)
.
(22)
The expected waiting time until k mutations have accumulated
according to the partial order P can be calculated in a fashion
similar to Eq. (18). Let J (P) ⊂ 2[d] denote the set of all geno-
types that are compatible with the poset P , i.e., the subsets
S ⊂ [d] for which j ∈ S and i ≺ j implies i ∈ S. Consid-
ering the set Ck(P) of all mutational pathways of length k in
J (P), we find
E[τk] =
∑
C∈Ck (P)
E[τk | C] Prob[C], (23)
with Prob[C] and E[τk | C] defined in Eqs. (19) and (20),
respectively. The set of possible paths Ck(P) is restricted to
the lattice J (P); hence the set of possible next mutations,
Exit(Ci ), is also constrained to the elements compatible with
the poset P . The expected waiting time for k mutations grows
with the number of relations because Exit(Ci ) is the larger, the
less relations exist in the poset. It is therefore maximal in a
totally ordered set, then decreases for a partial order, and is
minimal for an unordered set. The two opposing limit cases
of the linear chain and the independent case represent extrema
also in terms of the expected waiting time.
In practice, the number of mutational pathways can be large,
but the expectation, Eq. (23), can be computed recursively
without the need of enumerating all paths. The conjunctive
Bayesian network does not only allow for calculating the ex-
pected waiting time, but it has also nice statistical properties.
Both the parameters λ j and the structure P of the model can
be inferred efficiently from observed data. The maximum like-
lihood estimator for the parameters is
λˆ j = M∑M
i=1(ti j −max`∈pa( j) t`j )
, (24)
where M is the number of observations and the i-th obser-
vation ti · is a realization of T = (T1, . . . , Td). The maximum
likelihood poset Pˆ is the maximal poset that is compatible with
the data. In other words, Pˆ is simply the poset that contains all
compatible relations.
In practice, the occurrence times of mutations, T j , may not
be observable, but instead only mutational patterns are avail-
able. This setting gives rise to a censored version of the
conjunctive Bayesian network, in which parameter estimation
is still feasible using an Expectation-Maximization algorithm
(Beerenwinkel and Sullivant, 2008).
IV. POPULATION DYNAMICS
In the previous section we have treated genetic progression
as an effective process with steps including both mutation and
6clonal expansion that occur at effective rates λ j . We will now
dissect these two processes and analyze models with explicit
mutation and proliferation. Let µ denote the mutation rate.
We assume that each mutation increases fitness by the same
amount s in a multiplicative manner such that the fitness of a
cell with j mutations is (1+ s) j . Before analyzing the system
with both mutation and selection we first discuss this model for
s = 0. This corresponds to an ensemble of N independently
and identically distributed copies of the waiting time process.
For example, such a situation is found in the colon: It consists
of more than 106 crypts (Humphries and Wright, 2008), each
of which can develop an adenoma independently. The model
also applies to the case of selectively neutral mutations in a tis-
sue and we will present expressions for the waiting time until
the first cell has accumulated a given number of mutations.
4.1. Independent cell lineages
If s = 0, all cells have the same replicative capacity ir-
respective of their mutational patterns. Mutations therefore
accumulate independently in a neutral evolutionary process.
We can analyze this process by interpreting the independence
model with rates λ j = µ as describing the state of a single
cell. The population of genetically heterogeneous, but pheno-
typically identical cells can then be regarded as an ensemble of
independent cell lineages, each evolving according to Eq. (13).
In this setting, we are interested in the average time it takes
until the first cell with k mutations appears in a population of
size N , i.e., in the expectation of min{τ (i)k | i = 1, . . . , N },
where all τ (i)k are identical distributed according to Eq. (1) with
u j = (d − j + 1)µ.
Rather than calculating this expectation, we take a different
approach. Let τk be the waiting time for k  d independent
mutations, which is equivalently defined by the linear process
with rate µd, Eq. (15). In an ensemble of many identical cell
lineages the probabilities x j (t) = Prob[τ j < t] may be iden-
tified with the relative abundances of cells with j mutations in
the population. Similarly, Prob[τk < t] =∑ j≥k Pois( j;µdt)
is the fraction of cells having at least k mutations. When this
fraction exceeds 1/N , chances are high that the first cell has
accumulated k mutations. Thus, we define
τ ∗k = inf {t ≥ 0 | xk(t) ≥ 1/N }. (25)
This quantity can also be interpreted as the (1/N )-quantile of
the distribution of τk . Using Eq. (9), we can find τ ∗k by solving
1
N
= Pois(k;µdt)
∞∑
j=0
(µdt) j
(k + j) j . (26)
for t . Since N is typically very large (N = 106 to 109 cells),
we are searching for solutions in the regime where the right
hand side of Eq. (26) is small. This is the case for µdt  k.
Then only the j = 0 term of the sum contributes appreciably
and we have to solve 1/N = Pois(k;µdτ ∗k ).
For k = 1, we consider the subset of 1-cells, i.e., cells con-
taining one mutation, that starts growing in the background
of mutation-free cells as x1(t) = µdt exp(−µdt) ≈ µdt for
t ≈ 0. Thus the average waiting time to the appearance of
the first cell with one mutation is τ ∗1 ≈ 1/(µdN ). Simi-
larly, for k = 2, we find x2(t) = (1/2)(µdt)2 exp(−µdt) ≈
(1/2)(µdt)2 and thus x2(t) = 1/N has the approximate so-
lution τ ∗2 ≈
√
2/(µd
√
N ). Alternatively, one can arrive at
this approximation by considering the initial linear growth of
the population of 1-cells. The first 2-cell is produced by these
growing 1-cells when
µd
∫ τ∗2
0
x1(t) dt = 1N , (27)
having the same approximate solution given above.
In general, the solution of 1/N = Pois(k;µdτ ∗k ) is given
in terms of the Lambert W function, which is defined as the
solution of W (z)eW (z) = z,
τ ∗k = −
k
µd
W0
(
− k!
1/k
k N 1/k
)
, (28)
where W0 is the principle branch of W (Corless et al., 1996).
For large population sizes N , the argument of the Lambert W
function in Eq. (28) is close to zero and hence W (z) ≈ z. We
obtain
τ ∗k ≈
k!1/k
µd N 1/k
, for all k ≥ 1, (29)
which generalizes the approximations for τ ∗1 and τ ∗2 given
above.
On the other hand, for large k, we have k!1/k ≈ k/e and
N 1/k ≈ 1+ (log N )/k leading to
τ ∗k ≈
k2
eµd(k + log N ) . (30)
This approximation is less accurate, but reasonable for usual
parameter values and k = 0, . . . , 20 (Figure 3). For N = 1, it
coincides with the result for a single cell line, Eq. (15), up to a
constant factor of 1/e. The waiting time depends on the the in-
verse of the logarithm of the population size. For example, the
average waiting time to the first cell with k mutations among
109 cells is only about 20 times shorter than the same wait-
ing time in a single cell. For large k, this expression becomes
again linear in k (Figure 3).
The normal mutation rate due to DNA polymerase errors is
on the order of 10−10 to 10−9 base pairs (bp) per cell per gen-
eration (Kunkel and Bebenek, 2000). For an average human
gene size of 27kbp (Venter et al., 2001), the mutation rate per
gene should be on the order of µ ≈ 10−6 per cell per gener-
ation. The waiting time until the first of 109 cells has accu-
mulated k = 20 mutations would be on the order of 106 cell
generations which, in turn, typically occur at the time-scale of
days or weeks. Thus, the waiting time would be on the or-
der of 106 days or more, clearly exceeding a human lifetime.
Hence a neutral evolutionary process alone cannot account for
the genetic progression of cancer.
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FIG. 3 Approximate solutions of the waiting time τ∗k as defined by
the equation 1/N = Pois(k;µdτ∗k ), for N = 109, µd = 0.001, and
k = 1, . . . , 20. The exact solution in terms of the Lambert W function
(filled circles, Eq. (28)) is compared to the approximation given in
Eq. (29) (squares) and the less accurate but simpler approximation of
Eq. (30) (triangles).
4.2. Selection and clonal expansion
We now analyze the dynamics of an evolving cell population
in which each mutation confers the same selective advantage
s > 0. Because a new mutant with an additional mutation
has a growth advantage, it will expand in the tissue and out-
compete the other cells. The next mutation is most likely to
occur on this growing clone. We therefore use an evolutionary
model of carcinogenesis that accounts for mutation and selec-
tion (Beerenwinkel et al., 2007a) and trace the number of cells
with j mutations, N j (t), in each generation t = 0, 1, 2, . . . .
Consider a population of N cells that undergo subsequent
rounds of cell divisions as shown in Figure 4. In each gen-
eration, mutations occur randomly and independently at rate
µ. The total number of possible mutations is denoted d. We
assume that fitness, i.e., the expected number of offspring, is
proportional to (1+s) j , where j is the number of accumulated
mutations. The population dynamics are assumed to follow a
Wright-Fisher process (Ewens, 2004). In this model, genera-
tions are time-discrete and synchronized. A new configuration
[N0(t + 1), . . . , Nd(t + 1)] of cells is drawn from the previous
generation t according to the multinomial distribution
Prob [N0(t + 1) = n0, . . . , Nd(t + 1) = nd ]
= (n0 + · · · + nd)!
n0! · · · nd !
d∏
i=1
θ
n j
j ,
(31)
where n0 + · · · + nk = N . The parameters θ j denote the
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FIG. 4 Wright-Fisher process. Illustrated are four generations of a
single realization of the Wright-Fisher process with population size
N = 6. In each generation t + 1, cells are drawn randomly from
the previous generation t according to the multinomial distribution
given in Eq. (31). Directed edges (→) indicate the genealogy of this
realization. In general, cells with more mutations are more likely
to generate offspring and will therefore, on average, outcompete cells
with fewer mutations. In each generation, cells are subject to mutation
( ). In this realization, the waiting time to the first appearance of a
cell with k = 2 mutations was τ2 = 3 generations.
probability of sampling a j-cell,
θ j =
j∑
i=0
(
d − i
j − i
)
µ j−i (1− µ)d− j (1+ s)
i xi∑
l(1+ s)lxl
, (32)
where we defined x j (t) = N j (t)/N as the relative abundance
of j-cells. A cell with j mutations can occur in generation t+1
either as progeny of a j-cell in generation t , or by erroneous
duplication of a ( j−1)-cell. For s = 0 and infinitesimal gener-
ation times, the model reduces to the case of independent cell
lineages undergoing independent mutations, which has been
discussed in the previous section.
In general, no closed form solution of the Wright-Fisher
process is known. However, the dynamics defined by Eqs. (31)
and (32) display certain regularities that can be exploited in
order to derive an approximate analytical expression for the
expected waiting time to the first cell with k mutations, τ ∗k .
Numerical simulations show that the subsets of j-cells se-
quentially sweep through the population and the mutant waves
travel at constant speed (Beerenwinkel et al., 2007a). This reg-
ular behavior can be analyzed by decomposing the process into
the generation of a new cell type by mutation and its clonal ex-
pansion driven by selection.
The dynamics of clonal expansions are given by the replica-
tor equation (Nowak, 2006),
x˙ j (t) = sx j (t)
[
j −
∞∑
i=1
i xi (t)
]
, (33)
where we consider only those cell types that are already
present in the system and we ignore mutation. The fitness of
j-cells is (1+ s) j ≈ 1+ js, if s  1. Eq. (33) has a solution
in terms of the Gaussians x j (t) = A exp(−[ j − vt]2/[2σ 2])
with normalization constant A and width σ 2 = v/s, where
8v is the velocity of the traveling wave. The initial growth of
a newly founded clone is exponential, but eventually follows
this Gaussian distribution. The final decline corresponds to the
clone ultimately becoming extinct by outcompetition of fitter
clones harboring additional mutations.
The velocity of the waves is determined by the mutation pro-
cess. A new ( j + 1)-cell is generated by mutation from the
growing clone of j-cells. The equation x j+1(t) = 1/N can
therefore be rewritten, similar to Eq. (27), as∫ τ∗j+1
0
µdx j (t) dt = 1N , (34)
where initially, x j grows exponentially according to Eq. (33).
This approach finally yields the approximate expected waiting
time (Beerenwinkel et al., 2007a)
τ ∗k ≈
k log2(s/[µd])
2s log N
. (35)
This expression suggests approximating the Wright Fisher pro-
cess, Eqs. (31) and (32), by a linear multistep process, Eq. (1),
with transition rate u = (2s log N )/ log2(s/[µd]) in which
stages correspond to clonal expansions (Maley, 2007). Com-
paring Eq. (35) with the waiting time in a neutral evolutionary
process, Eq. (30), here the waiting time per mutation, 1/du,
contributes only logarithmically and the expected waiting time
Eq. (35) is proportional to k/s, reducing the overall waiting
time considerably. The reason for this acceleration lies in the
growth advantage of the mutated cells: A single cell produces
an exponentially growing number of clonal offspring. This
growth, in turn, directly relates to the probability of creating
a cell with an additional mutation. Therefore, clonal expan-
sions dramatically speed up the accumulation of mutations in
a population.
For example, considering a fitness advantage of s = 10−2
per mutation, d = 100 susceptible loci, a mutation rate of u =
10−7 per gene, and a population size of N = 109 cells results
in a waiting time of τ ∗20 ≈ 103 generations. With a generation
time of 1 to 2 days, this waiting time ranges on the time scale of
several years, being consistent with clinical observations. By
contrast, the waiting time in the neutral model is on the order
of 106 generations. Hence even a moderate selective advantage
decreases the waiting time by three orders of magnitude.
The time τ ∗j denotes the time after which the probability that
a cell with j mutations has been generated exceeds 1/N . This
is an approximation for the expected waiting time of the first
j-cell with an additional mutation in a population of size N .
For the Wright-Fisher process it is known, however, that due
to genetic drift the probability of fixation of a selectively ad-
vantageous mutation initially present in a single cell is only
2s (Ewens, 2004). Hence, the majority of mutated cells be-
come extinct. This is also observed in the numerical simu-
lations of the Wright-Fisher process (Eqs. (31, 32); Beeren-
winkel et al. (2007a)). On average it takes 1/2s cells un-
til the first successful mutant is generated. This effect is in-
cluded indirectly in approximation Eq. (35): x j (t) ∝ est is
the expected frequency conditioned only on x j (0) = 1/N and
not on survival. It also accounts for all trajectories, includ-
ing those going extinct. Recently, this effect has been stud-
ied in a related model (Brunet et al., 2008; Desai and Fisher,
2007). Desai and Fisher (2007) found an approximate waiting
time of τ ∗k ≈ k log(s/[ud])/(s[2 log N + log{sud}]). Compar-
ing with expression Eq. (35), the only difference is the term
log(sud) in the denominator. For typical parameter values,
log(sud) ≈ −7 ≈ − log N . Therefore, the waiting time is
larger by a factor of 1.5 as compared to Eq. (35). But this
comparison is limited, because the models are not identical.
For example, Desai and Fisher (2007) obtain a fixation proba-
bility of s, whereas in the Wright-Fisher model it is 2s.
V. CONCLUSION
A quantitative understanding of cancer progression is re-
quired for constructing clinical markers and for revealing rate-
limiting steps of this process. Here, we have analyzed waiting
time models for carcinogenesis and solved the equations defin-
ing the expected waiting times. Similar quantities have previ-
ously been shown to measure the degree of tumor progression
and to predict survival in cancer patients (Rahnenfu¨hrer et al.,
2005).
In the simplest case, carcinogenesis may be described by a
linear multistep process. The progression stages are generally
described by histological alterations and functional changes,
or on a molecular level, by mutation of certain genes and sub-
sequent clonal expansion. In a general multistep process, the
overall waiting time to reach stage k is the sum of the waiting
times of all predecessing steps.
If tumor stages are defined by the number of mutations that
have fixated in the cell population, then the progression dy-
namics depends on the order in which mutations accumulate.
For example, mutations may accumulate in a linear fashion,
according to a partial order, or completely independently. Lin-
ear accumulation is the slowest and independent progression
is the fastest. The acceleration can be considerable, especially
if many mutations are available that drive carcinogenesis.
The linear and the independent model present opposing lim-
its of the conjunctive Bayesian network family of models, in
which the mutations obey a partial order. The relations of the
poset may result from causal relationships among mutations,
such as the requirement in colon cancer for the tumor suppres-
sor APC to be mutated before other mutations are beneficial
and can fixate. The poset constraints induce a subset of muta-
tional pathways in the hypercube representing all combinato-
rial genotypes (Figure 2). Because the waiting time is additive
in the mutational pathways, its expected value for the conjunc-
tive Bayesian networks ranges between those for the linear and
the independent model.
We have discussed a particular instance of the Wright-Fisher
process, an evolutionary model comprising mutation and se-
lection. In this model, we find waiting times on the order of
20 years for a normal mutation rate and a selective advantage
of 1% per mutation. The successive clonal waves might be re-
garded as the stages in classical multistage theory. A neutral
evolutionary process can not explain the clinical progression of
9colon cancer, in which about 20 out of hundreds of mutations
accumulate in a time frame of 5 to 20 years. This process may
only be explained by advantageous mutations giving rise to
clonal expansions. These selective sweeps drastically increase
the chances of acquiring additional mutations the spreading
offspring.
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